This article was originally published in The Gray Sheet
Executive SummaryGains 510(k) clearance for the Vueport balloon occlusion guiding catheter with distal tip compliant balloon for access and enhanced visualization of the coronary venous system for VT mapping. Designed to temporarily occlude the coronary sinus, the catheter allows the physician to inject radiopaque dye to show the vasculature of the heart during fluoroscopy and produce a venogram, Cardima says
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.